Riskpilot← Back to searchSign inGet full accessINANOD AS
ASActiveOrg 916820267Nedre Skøyen Vei 11, 0276 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20161 employees
Revenue 2024
NOK 88K
-34% vs 2023
EBITDA margin
-196.5%
+2% vs 2023
Equity ratio
44.8%
Financial strength
Net profit 2024
NOK -760K
-34% vs 2023
| Revenue | NOK 88K | -34% |
| EBITDA | NOK -172K | +2% |
| Net profit | NOK -760K | -34% |
| Total assets | NOK 5,5M | +59% |
| Equity | NOK 2,5M | +113% |
| Employees | 1 | — |
Legal name
INANOD AS
Org number
916820267
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11. mars 2016
Share capital
NOK 41 466
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Fremstilling av medisiner og andre produkter som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet.
Address
Nedre Skøyen Vei 11, 0276 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 341 | 0 | 260 | 88 | 372 | 132 | 88 |
| Staff expenses | −0 | −97 | −0 | −0 | −0 | −0 | −0 | −244 | −482 |
| EBITDA | 0 | −469 | 301 | −83 | −13 | −39 | 138 | −176 | −172 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −382 | −575 |
| EBIT | 0 | −469 | 301 | −83 | −13 | −39 | 138 | −558 | −747 |
| Net financials | 0 | 0 | 0 | 0 | −1 | −0 | 1 | −8 | −13 |
| Profit before tax | 0 | −469 | 301 | −82 | −14 | −40 | 140 | −566 | −760 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −469 | 301 | −82 | −14 | −40 | 140 | −566 | −760 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 30 | 722 | 1 428 | 1 688 | 1 697 | 1 797 | 1 932 | 3 442 | 5 482 |
| Equity | 30 | −439 | 1 395 | 1 593 | 1 579 | 1 581 | 1 721 | 1 155 | 2 458 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 012 | 2 890 |
| Short-term debt | 0 | 1 161 | 33 | 95 | 118 | 216 | 211 | 275 | 134 |
| Total debt | 0 | 1 161 | 33 | 95 | 118 | 216 | 211 | 2 287 | 3 024 |
EBITDA margin
-196.5%
This company
15.8%
Market median
-1344% vs market
20162024
Equity ratio
44.8%
This company
38.2%
Market median
+17% vs market
20162024
Return on equity
-30.9%
This company
18.4%
Market median
-268% vs market
20162024
Net profit margin
-868.7%
This company
8.1%
Market median
-10825% vs market
20162024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20162024
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
20162024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NS Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 6.3% | 6.3% | 2022 | |
Konsulent 1 As | Company | 4.3% | 4.3% | 2022 |
Remis As | Company | 2.0% | 2.0% | 2022 |
Smerud Medical Research International As | Company | 1.7% | 1.7% | 2022 |
Chijioke Igwe | Company | 1.7% | 1.7% | 2022 |
Igwe Ukagha | Company | 1.7% | 1.7% | 2022 |
Sikt As | Company | 1.7% | 1.7% | 2022 |
| Individual | 1.4% | 1.4% | 2022 | |
Hermitage Holding As | Company | 1.0% | 1.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of INANOD AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nalinava Sengupta | Chief Executive Officer | 0 companies |
| Jørn Lein-Mathisen | Board of Directors | 0 companies |
| Per Antonius Foss | Board of Directors | 0 companies |
| Åge Nærdal | Chairman | 0 companies |
| Thomas Due | Board of Directors | 0 companies |
| Stener Kvinnsland | Board of Directors | 0 companies |